An overview of vaccine development for COVID-19-Reference-Cited by-同舟云学术

An overview of vaccine development for COVID-19

Published:2021-03 Issue:3 Volume:12 Page:235-244
ISSN:2041-5990
Container-title:Therapeutic Delivery
language:en
Short-container-title:Therapeutic Delivery

Author:

Shahcheraghi Seyed H¹²,Ayatollahi Jamshid¹,Aljabali Alaa AA³^ORCID,Shastri Madhur D⁴,Shukla Shakti D⁵^ORCID,Chellappan Dinesh K⁶^ORCID,Jha Niraj K⁷^ORCID,Anand Krishnan⁸,Katari Naresh K⁹,Mehta Meenu¹⁰¹¹,Satija Saurabh¹⁰¹¹,Dureja Harish¹²^ORCID,Mishra Vijay¹¹^ORCID,Almutary Abdulmajeed G¹³,Alnuqaydan Abdullah M¹³,Charbe Nitin¹⁴^ORCID,Prasher Parteek¹⁵^ORCID,Gupta Gaurav¹⁶^ORCID,Dua Kamal¹⁰^ORCID,Lotfi Marzieh²¹⁷,Bakshi Hamid A¹⁸,Tambuwala Murtaza M¹⁸^ORCID

Affiliation:

1. Infectious Diseases Research Center, Shahid Sadoughi Hospital, Shahid Sadoughi University of Medical Sciences, Yazd, Iran

2. Department of Medical Genetics, School of Medicine, Shahid Sadoughi University of Medical Sciences, Yazd, Iran

3. Department of Pharmaceutics & Pharmaceutical Technology, Yarmouk University, Irbid, Jordan

4. School of Pharmacy & Pharmacology, University of Tasmania, Hobart, Australia

5. Priority Research Centre for Healthy Lungs, School of Medicine & Public Health, The University of Newcastle, Callaghan, Australia

6. Department of Life Sciences, School of Pharmacy, International Medical University, Kuala Lumpur, Malaysia

7. Department of Biotechnology, School of Engineering & Technology, Sharda University, Greater Noida, Uttar Pradesh, India

8. Department of Chemical Pathology, School of Pathology, Faculty of Health Sciences & National Health Laboratory Service, University of the Free State, Bloemfontein, South Africa

9. Department of Chemistry, School of Science, GITAM Deemed to be University, Hyderabad 502329, India

10. Discipline of Pharmacy, Graduate School of Health, University of Technology Sydney, Ultimo, NSW 2007, Australia

11. School of Pharmaceutical Sciences, Lovely Professional University, Phagwara 144411, Punjab, India

12. Faculty of Pharmaceutical Sciences, Maharshi Dayanand University, Rohtak, India

13. Department of Medical Biotechnology, College of Applied Medical Sciences, Qassim University, Saudi Arabia

14. Departamento de Química Orgánica, Facultad de Química y de Farmacia, Pontificia Universidad Católica de Chile, Av. Libertador Bernardo O’Higgins, Santiago 340, Región Metropolitana, Chile

15. Department of Chemistry, University of Petroleum & Energy Studies, Dehradun 248007, India

16. School of Pharmaceutical Sciences, Suresh Gyan Vihar University, Jaipur, India

17. Abortion Research Center, Reproductive Sciences Institute, Shahid Sadoughi University of Medical Sciences, Yazd, Iran

18. School of Pharmacy & Pharmaceutical Sciences, Ulster University, Coleraine, County Londonderry, Northern Ireland, BT52 1SA, UK

Abstract

The COVID-19 pandemic continues to endanger world health and the economy. The causative SARS-CoV-2 coronavirus has a unique replication system. The end point of the COVID-19 pandemic is either herd immunity or widespread availability of an effective vaccine. Multiple candidate vaccines – peptide, virus-like particle, viral vectors (replicating and nonreplicating), nucleic acids (DNA or RNA), live attenuated virus, recombinant designed proteins and inactivated virus – are presently under various stages of expansion, and a small number of vaccine candidates have progressed into clinical phases. At the time of writing, three major pharmaceutical companies, namely Pfizer and Moderna, have their vaccines under mass production and administered to the public. This review aims to investigate the most critical vaccines developed for COVID-19 to date.

Publisher

Future Science Ltd

Subject

Pharmaceutical Science

Link

https://www.future-science.com/doi/pdf/10.4155/tde-2020-0129

Reference70 articles.

1. The COVID‐19 epidemic

2. COVID-19 infection: Emergence, transmission, and characteristics of human coronaviruses

3. Amawi H, Abu Deiab Ga I, A Aljabali AA, Dua K, Tambuwala MMJTd. COVID-19 pandemic: an overview of epidemiology, pathogenesis, diagnostics and potential vaccines and therapeutics. 11(4), 245–268 (2020).

4. Aljabali AA, Bakshi HA, Satija S COVID-19: underpinning research for detection, therapeutics, and vaccines development. 8(4), 323–353 (2020).

5. Research and Development on Therapeutic Agents and Vaccines for COVID-19 and Related Human Coronavirus Diseases

Cited by 48 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Protein subunit vaccines: Promising frontiers against COVID-19;Journal of Controlled Release;2024-02

2. Health service factors affecting the COVID-19 vaccination campaign in a Ghanaian metropolis: A qualitative exploratory study;BMJ Open;2023-12

3. A Critical Assessment of COVID-19 Genomic Vaccines;Current Topics in Medicinal Chemistry;2023-10

4. Management and Characteristics of Embolism and Thrombosis After COVID-19 Vaccination: Scoping Review;Journal of Multidisciplinary Healthcare;2023-09

5. Looking for SARS-CoV-2 Therapeutics Through Computational Approaches;Current Medicinal Chemistry;2023-08